Key facts
- Akido Labs’s last known valuation is $395.0M (May 2025).
- It has raised $109.2M across 1 recorded rounds; the latest was Later Stage VC ($84.3M) in Mar 2025.
- Notable investors include Plug and Play Tech Center, Y Combinator, Soma Capital, Astir Ventures, DCVC — 37 tracked in total.
- Akido Labs has filed 1 Form D with the SEC, most recently May 2025 ($84.3M sold to 94 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 37 names
- ·Watchlist + deal alerts for Akido Labs
Funding rounds
1 roundsAbout Akido Labs
Developer of a reimagined healthcare system designed to bridge technology and empathy to make exceptional healthcare a basic human right. The company's system leverages artificial intelligence and state-of-the-art security technology to offer streamlined diagnosis, optimized diagnostics, personalized treatment, and forecasted health risks to protect data while providing innovation and transforming the health system, enabling health institutions and innovators to use the information to drive transformational change and radically improve the quality of life and affordability of care for underserved people.
- Sector
- Healthcare
- HQ
- West Hollywood, CA, United States
- Founded
- 2015
- Employees
- 1,000
- Website
- akidolabs.com/
- Ownership
- Privately Held (backing)
Akido Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Akido Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Akido Labs in its N-PORT filings yet. We sweep new filings monthly.